Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Boess

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Environmental Health Perspectives|September 4, 2004
Discriminating different classes of toxicants by transcript profilingGuido Steiner, Laura Suter, Franziska Boess, et al.
Toxicology and Applied Pharmacology|January 29, 2013
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicityRadina Kostadinova, Franziska Boess, Dawn Applegate, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Modulation of gene and protein expression by carbon tetrachloride in the rat liverMichael Fountoulakis, Maria-Christina de Vera, Flavio Crameri, et al.
Toxicology|February 9, 2017
Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitroFranziska Boess, Barbara Lenz, Juergen Funk, et al.
Toxicology and Applied Pharmacology|July 2, 2005
Assessment of hepatotoxic liabilities by transcript profilingStefan Ruepp, Franziska Boess, Laura Suter, et al.
Plos One|July 22, 2016
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide DrugsSabine Sewing, Franziska Boess, Annie Moisan, et al.
Journal of Biochemical and Molecular Toxicology|June 15, 2011
Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug developmentAdrian Roth, Franziska Boess, Christian Landes, et al.
Journal of Molecular Endocrinology|March 7, 2013
Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and manFranziska Boess, Cristina Bertinetti-Lapatki, Sannah Zoffmann, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2020
Combining In Vivo and Organotypic In Vitro Approaches to Assess the Human Relevance of Basimglurant (RG7090), a Potential CAR ActivatorRamona Nudischer, Kasper Renggli, Cristina Bertinetti-Lapatki, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2018
Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus InhibitorNicole A Kratochwil, Miriam Triyatni, Martina B Mueller, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Environmental Health Perspectives|September 4, 2004
Discriminating different classes of toxicants by transcript profilingGuido Steiner, Laura Suter, Franziska Boess, et al.
Toxicology and Applied Pharmacology|January 29, 2013
A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicityRadina Kostadinova, Franziska Boess, Dawn Applegate, et al.
Toxicology and Applied Pharmacology|September 10, 2002
Modulation of gene and protein expression by carbon tetrachloride in the rat liverMichael Fountoulakis, Maria-Christina de Vera, Flavio Crameri, et al.
Toxicology|February 9, 2017
Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitroFranziska Boess, Barbara Lenz, Juergen Funk, et al.
Toxicology and Applied Pharmacology|July 2, 2005
Assessment of hepatotoxic liabilities by transcript profilingStefan Ruepp, Franziska Boess, Laura Suter, et al.
Plos One|July 22, 2016
Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide DrugsSabine Sewing, Franziska Boess, Annie Moisan, et al.
Journal of Biochemical and Molecular Toxicology|June 15, 2011
Gene expression-based in vivo and in vitro prediction of liver toxicity allows compound selection at an early stage of drug developmentAdrian Roth, Franziska Boess, Christian Landes, et al.
Journal of Molecular Endocrinology|March 7, 2013
Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and manFranziska Boess, Cristina Bertinetti-Lapatki, Sannah Zoffmann, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 28, 2020
Combining In Vivo and Organotypic In Vitro Approaches to Assess the Human Relevance of Basimglurant (RG7090), a Potential CAR ActivatorRamona Nudischer, Kasper Renggli, Cristina Bertinetti-Lapatki, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 18, 2018
Simultaneous Assessment of Clearance, Metabolism, Induction, and Drug-Drug Interaction Potential Using a Long-Term In Vitro Liver Model for a Novel Hepatitis B Virus InhibitorNicole A Kratochwil, Miriam Triyatni, Martina B Mueller, et al.
Pageof 3